The formulated nanoparticle Tf-LPN-G3139 with optimized nitrogen to phosphate (N/P) ratio was characterized for stability, cellular uptake in AML cell line MV4-11, in vitro pharmacology, and in vivo anticancer activity in MV4-11 tumor-bearing mouse model. Here, TF is linked to acute myeloid leukemia.